These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 37581270

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ApaI, BsmI and TaqI VDR gene polymorphisms in association with multiple sclerosis in Slovaks.
    Čierny D, Michalik J, Škereňová M, Kantorová E, Sivák Š, Javor J, Kurča E, Dobrota D, Lehotský J.
    Neurol Res; 2016 Aug; 38(8):678-84. PubMed ID: 27338176
    [Abstract] [Full Text] [Related]

  • 5. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
    Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner-Scott J.
    Mult Scler; 2012 Jan; 18(1):16-22. PubMed ID: 21816760
    [Abstract] [Full Text] [Related]

  • 6. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J, Čierny D, Kantorová E, Kantárová D, Juraj J, Párnická Z, Kurča E, Dobrota D, Lehotský J.
    Neurol Res; 2015 Jan; 37(12):1060-7. PubMed ID: 26744784
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D3 receptor ( VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis.
    García-Martín E, Agúndez JA, Martínez C, Benito-León J, Millán-Pascual J, Calleja P, Díaz-Sánchez M, Pisa D, Turpín-Fenoll L, Alonso-Navarro H, Ayuso-Peralta L, Torrecillas D, Plaza-Nieto JF, Jiménez-Jiménez FJ.
    PLoS One; 2013 Jan; 8(6):e65487. PubMed ID: 23840333
    [Abstract] [Full Text] [Related]

  • 8. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J, Párnická Z, Michalik J, Čopíková-Cudráková D, Shawkatová I, Ďurmanová V, Gmitterová K, Klímová E, Bucová M, Buc M.
    J Neurol Sci; 2015 Feb 15; 349(1-2):138-42. PubMed ID: 25604634
    [Abstract] [Full Text] [Related]

  • 9. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.
    Čierny D, Lehotský J, Kantorová E, Sivák Š, Javor J, Kurča E, Dobrota D, Michalik J.
    Neurol Res; 2018 Jul 15; 40(7):607-614. PubMed ID: 29619906
    [Abstract] [Full Text] [Related]

  • 10. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R, Samadzadeh S, Sabokbar T, Siroos B, Armaki SA, Aslanbeiki B, Ghelman M, Taheri T, Shakoori A.
    J Neurol Sci; 2014 Oct 15; 345(1-2):92-6. PubMed ID: 25064442
    [Abstract] [Full Text] [Related]

  • 11. VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
    Ďurmanová V, Shawkatová I, Javor J, Párnická Z, Čopíková-Cundráková D, Turčáni P, Lisá I, Gajdošechová B, Buc M, Bucová M.
    Folia Biol (Praha); 2015 Oct 15; 61(1):8-13. PubMed ID: 25958306
    [Abstract] [Full Text] [Related]

  • 12. HLA-DRB1*15:01 and multiple sclerosis: a female association?
    Irizar H, Muñoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Triviño T, Prada A, Saenz-Cuesta M, De Juan D, Lopez de Munain A, Olascoaga J, Otaegui D.
    Mult Scler; 2012 May 15; 18(5):569-77. PubMed ID: 22127897
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks.
    Čierny D, Michalik J, Dubovan P, Škereňová M, Javor J, Kurča E, Dobrota D, Lehotský J.
    J Neuroimmunol; 2019 May 15; 330():123-129. PubMed ID: 30875612
    [Abstract] [Full Text] [Related]

  • 16. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
    Balnyte R, Rastenyte D, Vaitkus A, Mickeviciene D, Skrodeniene E, Vitkauskiene A, Uloziene I.
    BMC Neurol; 2013 Jul 09; 13():77. PubMed ID: 23837503
    [Abstract] [Full Text] [Related]

  • 17. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P, Attar M, Rahimian M, Fathi D, Shahbazi M.
    Iran J Immunol; 2017 Sep 09; 14(3):231-239. PubMed ID: 28919586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
    Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T.
    Eur J Neurol; 2011 Feb 09; 18(2):337-342. PubMed ID: 20629714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.